Pages that link to "Q77397574"
Jump to navigation
Jump to search
The following pages link to Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus (Q77397574):
Displaying 13 items.
- Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes (Q26778095) (← links)
- Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study. (Q33426771) (← links)
- Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes (Q33622266) (← links)
- Acarbose treatment and the risk of cardiovascular disease in type 2 diabetic patients: a nationwide seven-year follow-up study (Q34100788) (← links)
- Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. (Q34541875) (← links)
- Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus? (Q35109112) (← links)
- Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations (Q36333089) (← links)
- Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? (Q36417137) (← links)
- Extracts of Coreopsis tinctoria Nutt. Flower Exhibit Antidiabetic Effects via the Inhibition of α-Glucosidase Activity (Q36760425) (← links)
- On the potential of acarbose to reduce cardiovascular disease (Q37717838) (← links)
- Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes (Q43890331) (← links)
- Efficacy of acarbose in Chinese subjects with impaired glucose tolerance (Q44579054) (← links)
- Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus (Q51483484) (← links)